Independent Wealth Network Inc. Takes $105,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Independent Wealth Network Inc. acquired a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the fourth quarter, Holdings Channel.com reports. The fund acquired 11,238 shares of the pharmacy operator’s stock, valued at approximately $105,000.

Several other large investors have also added to or reduced their stakes in WBA. First Financial Corp IN increased its holdings in shares of Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares during the period. TD Private Client Wealth LLC increased its stake in Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 3,208 shares during the last quarter. Sentry Investment Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $30,000. Eastern Bank bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter valued at about $33,000. Finally, Strategic Investment Solutions Inc. IL purchased a new position in shares of Walgreens Boots Alliance during the second quarter worth about $34,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Up 1.0 %

Shares of Walgreens Boots Alliance stock opened at $11.74 on Friday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $23.76. The business’s 50 day simple moving average is $9.73 and its two-hundred day simple moving average is $9.86.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.66 earnings per share. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.59 EPS for the current year.

Analyst Ratings Changes

WBA has been the topic of a number of recent analyst reports. Barclays raised their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. TD Cowen dropped their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. UBS Group upped their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. Morgan Stanley lowered their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research report on Friday, October 11th. Finally, Bank of America upped their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $13.27.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.